Introduction
Alzheimer's disease (AD) is a neurodegenerative disease characterized by accumulation of insoluble intraneuronal inclusions, such as neurofibrillary tangles and extracellular neuritic senile plaques. The insoluble intraneuronal inclusions are formed from interconnected, paired helical filaments (PHFs) (Appelt and Balin, 1993; Ohtsubo et al., 19W) , which are composed predominantly of the microtubule-associated protein tau (Lee et al.. 1331;  Greenberg and Davies, 1990; Price et al., 1989; Selkoe, 1989) . The mechanism leading to the formation of insoluble macromolecular complexes from normal neuronal cytoskeletal proteins, and in particular the tau protein, has yet to be determined. Post-translational modifications of cytoskeletal proteins, such as phosphorylation and glycation (Ledesma et al., 19%; Yan et al., 1994) , have been suggested as factors that contribute to the pathogenesis of AD. Other covalent modifications to cytoskeletal proteins also may contribute to the overall formation of insoluble proteolysis-resistant protein complexes. These modifications may include enzymatic reactions catalyzed by intracellular transglutaminase(s).
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Transglutaminases ('Eases) are Ca2+-dependent enzymes that catalyze the formation of covalent. stable isopeptide bonds which are resistant to proteolysis. This enzymatic reaction is an acyl transfer between the carboxamide group of a peptide-bound glutamine residue and the &-amino group of a peptide-bound lysine. Alternatively, the primary amino group of a polyamine can form an &-(y-glutamyl) lysine or (y-glutamyl) polyamine bond between proteins (Folk and Finlayson, 1977) . These enzymes have been localized in plasma, tissues, and exuacellulv fluids. Functionally, TGascs have also been implicated in neuronal differentiation, (Byrd and Lichti, 1987) maturation (Hand et al., 1993b) , and apoptosis (Iwaki et al., 1994; Alaoui et al., 1992) . Cellular TGascs have been lacalized and characterized in neuroblastomas (Piacentini et al., 1992; Maccioni and Seeds, 1986), gliomas (Komer and Backrach, 1985; Iwaki et al., 1994) . and rat neuronal tissues (Facchiano et al., 1993; Hand et al., 1993b; Reichelt and Poulsen, 1992; Gilad and Varon, 1985) . However, the localization and characterization of cellular E a s e in the human brain have not been demonstrated. Earlier studies using crude human brain extracts demonstrated biochemically that TGase activity was apparent in the human brain (Selkoe et al., 1982) . The focus of this investigation is the localization of intraneuronal TGase(s) in the human brain, specifically from the hippocampus, an area highly vulnerable to the neurodegeneration characteristic of AD. Using immunocytochemistry and immunofluorescence, we have localized a neuronal tissue E a s e in rat hippocampal cells and in human hippocampal neurons from the CAI to the CA4 layer and in the dentate gyrus from both normal aged APPELT, KOPEN, BOYNE, BMIN and AD brains. Our results indicate a more prominent neuronal immunoreactivity for tissue %e in the AD brain containing abundant degenerating neurons compared to normal aged brain. These findings suggest that E a s e may be associated with the neurodegenerative processes characteristic of AD.
Materials and Methods
Tissue Collection. Tissues from the human CNS were collected from two normal aged individuals (ages 71 and 74 years), from three AD individuals (ages 70, 75, and 79 years) confirmed at autopsy, and from one Down syndrome (DS) individual (age 42 years) with neuropathological findings of AD, using the National Institute on Aging criteria (Khachaturian, 1985) . The diagnoses were confirmed by histopathology using the recommended protocol (CERAD; Mirra et al., 1991) at the Medical College of Pennsylvania & Hahnemann University, Neuropathology Division, Department of Pathology & Laboratory Medicine. The postmortem interval (PMI) ranged from 2 to 24 hr. Of the tissue collected, half of the brain was used fresh or frozen at -7O'C for biochemical isolation of proteins, and the remaining tissue was formalin-fixed and paraffin-embedded for sectioning and immunocytochemistry/immunofluorescence evaluation.
Cell Culture. Embryonic rat hippocampal cells were grown in culture with cortical glia as previously described (Boyne et al., 1995; Romano-Clarke, 1990 Bartlett and Banker, 1984; Banker and Cowan, 1977) . Briefly, the hippocampi from embryonic Day 18 Spngue-Dawley rat fetuses were dissected from surrounding brain, treated for 15 min in 0.25% trypsin (Sigma; St Louis, MO), washed in Ca+2,Mg+2-free balanced salt solution, and dissociated by trituration through Pasteur pipettes of decreasing bore size. The cells were plated onto polylysine-coated glass coverslips at 53-212 cellsh". After incubation in Dulbecco's minimal essential medium with 10% fetal calf serum (FCS) for 4 hr, coverslips were transferred to 60" Petri plates containing a monolayer of cortical glial cells maintained in defined media (Bartlett and Banker, 1984) . The neuronbearing coverslips were inverted to face the glia and were separated by a 0.5-1-mm paraffin barrier.
Immunofluorescence. Rat hippocampal cells were grown on coverslips for 3-7 days and fixed in 4% paraformaldehyde and 0.1% glutaraldehyde in PBS for 10 min, permeabilited with 0.1% Triton X-100 for 2 min, and rinsed with PBS. The cells wefe blocked with 1% wlv nonfat dry milk for 30 min and incubated with anti-coagulation Factor XIIIa a-subunit from human placenta (Calbiwhem; LaJolla, CA) diluted 1:25 in 1% nonfat milk for 2 hr at room temperature (RT), rinsed, and exposed to an anti-rabbit secondary antibody conjugated to FITC (fluorescein) (Jackson Immunoresearch; Avondale, PA) diluted 1:SO in 1% w/v nonfat dry milk. Coagulation Factor XIIIa is an extracellular E a s e involved in the coagulation cascade and has homology with tissue TGases (Greenberg et al., 1991) . Controls included incubation of the cells without the primary antibody, followed by incubation with the specific secondary antibody. The positive control included incubation with an unrelated specific primary antibody (mouse anti-tubulin, undilute supernatant; courtesy of Dr. Ken Blank) and the specific secondary antibody conjugated to F I X The cells were rinsed repeatedly, mounted with Vectashield mounting medium (Vector Labs; Burlingame, CA), and viewed with a Leitz Laborlux microscope and photographed with T-Max 400 film (Kodak; Rochester, NY).
Sections of hippocampi from formalin-fixed, paraffh-embedded ADlDS brains were rinsed in xylene, followed by graded alcohols 100-70%. They were then placed in 10 mM sodium citrate, pH 6.0, and microwaved for 15 min. The sections remained in the citrate buffer for an additional 15 min, after which they were rinsed in 4'C double-distilled Hz0 and placed in PBS with normal goat serum, pH 7.4, for 5 min. These sections were further blocked with normal swine serum (Dako: Santa Barbara, CA) for 10 min, followed by incubation for 30 min with PHFl (1:250 dilution). The sections were then rinsed in PBS, blocked a second time with normal goat serum in PBS for 5 min, and incubated for 30 min in TRITC (rhodamine)-labeled goat anti-mouse secondary antibody (150) (Southern Biotech; Birmingham, AL) that was preabsorbed with normal rat serum. After a rinse in PBS alone and PBS with normal goat serum for 5 min, the sections were incubated with anti-Factor XIIIa (1:>0) for 30 min. Then the sections were again rinsed in PBS and blocked in PBS with normal goat serum for 5 min, followed by incubation for 30 min in FITC-labeled goat anti-rabbit secondary antibody (1%) (Southern Biotech) preabsorbed with mouse and human serum. The sections were rinsed repeatedly in PBS, mounted, and viewed and photographed on either a Leitz Laborlux or an Olympus microscope. Controls for these experiments included (a) incubation of the sections without primary antibodies and with specific secondaries, (b) incubation with primary antibodies without secondaries, and (c) incubation with primary antibodies followed by nonspecific secondary antibodies.
Immunocytochemistry. Sections from formalin fixed, paraffin-embedded human brains were rinsed in xylene, followed by graded alcohols 100-70%. Sections were transferred to 3% H202 for 15 min, placed in 10 mM sodium citrate, pH 6.0, and microwaved for 15 min. These sections remained in sodium citrate buffer for an additional 15 min and were rinsed in warm double-distilled Hz0, followed by a rinse in 4'C double-distilled H20. Subsequently, they were blocked in 0.1% cold water fish gelatin (CWFG Sigma) in PBS, pH 7.4, for 5 min. The sections were incubated in normal swine serum (Dako) for 10 min, followed by incubation for 30 min with the primary antibody anti-Factor XIIIa at a dilution of 1:>0-1:200. Sections were rinsed with PBS and blocked in 0.1% CWFG in PBS for 5 min. Then the sections were incubated in biotinylated anti-rabbit secondary for 15 min. The sections were tinsed in PBS with 0.1% CWFG, pH 7.4, followed by incubation in streptavidin complex for 15 min. After a rinse in PBS, the sections were reacted with diaminobenzidine for 2-5 min, counterstained with hematoxylin, and mounted. The negative control sections were treated as previously described but were reacted with nonimmune serum as the primary antibody and did not demonstrate crossreactivity. Representative sections were viewed with either a Leitz Orthoplan or an Olympus microscope and photographed on Ektachrome l60T color slide film (Kodak).
Biochemistry and Immunoblotting. The hippocampal regions (~0 . 8 -1.4 g wet weight) from autopsy brains of normal aged individuals and from ADlDS brains were homogenized in 1-2.5 ml of 1 x RAB buffer (consisting of 0.1 M MES. 1.0 mM EGTA, 0.75 M NaCI, 0.5 mM MgCI2, 0.5 mM PMSF, 4% leupeptin, and 0.01% Triton X-100, pH 6.9, at 4'C). The samples were stirred at 4°C for 1 hr and centrifuged at 1000 x g for 30 min at 4'C. These supernatants were centrifuged at 200,000 x g for 1 hr at 4'C. Laemmli sample buffer was added to these remaining supernatants containing the TGase(s) before boiling for 5 min, and were analyzed by SDS-PAGE, followed by Western blotting with anti-Factor XIIIa at dilutions of 1:50-1:100. Controls included incubations of nitrocellulose transfers of purified human recombinant tau (courtesy of Dr. Michel Goedcrt) and bovine tau with anti-Factor XIIIa.
Rat hippocampal cells were grown to confluence in 60-mm dishes over 12 days. These cells were collected and centrifuged at 1000 x g for 5 min and resuspended in 500 pl of 1 x RAB buffer at 4'C. The cells were homogenized and analyzed on 10% SDS-PAGE by Coomassic blue G staining and by Western blotting with anti-Factor XIIIa after ttansfer to nitrocellulose membranes.
Immunoabsorption. The anti-Factor XIIIa polyclonal antibody (1.5 Nglpl) was incubated with coagulation factor XI11 (2 pglpl) for 2 hr at RT before the immunoblotting experiments with guinea pig liver tissue E a s e to determine if this preabsotption would eliminate immunoreactivity for tissue Ease.
The preabsorbed anti-Factor XIIIa antibody that was used for immu-noblotting and immunocytochemistry was derived from coupling guinea pig livcr TGasc (2 pgIpI) to cyanogen-bromide-activated Sepharosc 4B for 2 hr at RT. followed by incubating anti-Factor XIlla with thc coupled Scpharosc for 12-16 hr at RT according to an established protocol from Pharmacia (Uppsala. Swcdcn). The eluent obtained from this incubation contained the prcabsorbcd anti-Factor Xllla.
Results

Biochemistry
Tissue-type TGases were identified from homogenates of the hippocampi of normal aged and ADlDS brains as well as from homogenates of rat hippocampal neurons from cultures in vitro. Embryonic rat hippocampal neurons were utilized initially because E a s e activity has been recognized within the developing rat CNS (Perry and Haynes, 1993) . The anti-Factor XIIIa antibody was shown to immunolabel purified coagulation Factor XI11 and Factor XIIIa TGase preps from m a l aged human hippocampi (Lane 4) and AD hippocampi (Lane 5). both of which were immunoreacted with anti-Factor Xllla preabsorbed with guinea pig liver tissue TGase.
and. in addition, to recognize guinea pig liver tissuelGase, a wellcharacterized cellularltissue E a s e ( Figure 1A) . This specific immunoreactivity enabled us to examine human brain tissues with an antibody that recognizes tissue E a s e . since other well-characterized monoclonal and polyclonal antibodies do not immunolabel human brain. The TGascs were identified by using anti-coagulation Factor XIIIa on Westem blots of the homogenates ( Figure 1B) . TGax immunoreactivity was apparent in rat hippocampal neurons and in preparations from normal aged and ADlDS hippocampi. To determine whether or not the polyclonal antibody that recognized tissue E a s e was specific for tissue TGase(s) found in preparations from human brain, the polyclonal was preabsorbed with guinea pig liver tissue E a s e . After this preabsorption, the immunoreactivity to brain Ease(s) was reduced or eliminated in the molecular mass ranges comparable to guinea pig liver tissue E a s e ( Figure  lB, Lanes 4 and 5 ) . An exception to these results was the continued immunoreactivity of high >200-KD protein bands within the brain preparations ( Figure 1B, Lanes 4 and 5 ) . This immunoreactivity most likely corresponds to the immunolabeling retained around cerebral blood vessels after preabsorption experiments (see Figure  3C ). Previous reports indicate that high molecular mass >200-KD crosslinked Factor XI11 could be found within the extracellular matrix from various cell types (Banigian et al., 1991; Barry and Mosher, 1990) . The apparent molecular weights of the tissue IK;axs ranged from -50 to >200 KD. Guinea pig liver tissue Tcasc demonstrated several bands at 4 5 -9 7 KD. In contrast, purified Factor XI11 and Factor XIIIa were immunoreactive at -80 KD under the reducing conditions of our electrophoresis protocol. This is representative of Factor XI11 from human plasma, in which Factor XI11 is a tetramer of -320 KD composed of two a-subunits and two b-subunits (Schwartz et al., 1973) . Homogenates of rat hippocampal neurons demonstrate tissue TGase immunoreactive bands at -55-64 KD and those of normal aged and AD human brain hippocampal tissues at -50 to >200 KD. Controls for immunolabeling demonstrated that anti-Factor XIIIa was not immunoreactive with tau proteins.
Light Microscopy
To determine the extent and specificity of neuronal immunolabeling by the anti-Factor XIIIa antibody, embryonic rat neurons (Days 3-7) were immunoreacted with this antibody, followed by incubation with specific secondaries conjugated with FIX ( Figure 2 ). Neurons from Day 3 exhibited immunolabeling throughout the perikaryal cytoplasm and dendritic processes, which included prominent spikes (Figure 2A ). By Day 7, the perikaryon remained immunoreactive, with light immunoreactivity throughout the welldeveloped processes ( Figure 2B) .
Sections from formalin-fixed AD hippocampal tissues were Bodian-stained and immunolabeled for ubiquitin to reveal many neuritic senile plaques and neurofibrillary tangle-containing neurons throughout the hippocampus (data not shown). Within the AD hippocampus, less intense immunolabeling was evident within neurons not containing tangles using anti-Factor XIIIa (Figures 3A  and 3B ). whereas degenerating neurons containing apparent neurofibrillary tangles showed strong immunopositivity ( Figure 3B) . Immunolabeling for E a s e also was identified within the walls of However, by 7 days (B) , the most prominent immunofluorescent labeling appears to be confined to the perikaryon. Original magnification x 240. Bar = 40 pm. many blood vessels in the AD hippocampal tissues. Hippocampal neurons within AD tissue incubated with the preabsorbed anti-Factor XIIIa antibody were not immunolabeled, although blood vessels in the same tissues were immunoreactive, comparable to their labeling before preabsorption of the antibody ( Figure 3C ). This immunoreactivity most likely results from the presence of crosslinked Factor XI11 and/or of endothelial cell E a s e found within the walls of cerebral blood vessels, similar to the TGases found within the extracellular matrix from various cell types (Barsigian et al., 1991; Barry and Mosher, 1990) .
In sections from the normal aged hippocampus compared to the AD hippocampus, the intensity of immunolabeling was diminished throughout the tissue sections after immunolabeling with anti-Factor XIIIa (not preabsorbed) ( Figure 3D ). Immunolabeling of normal aged tissues was less dramatic overall than that observed in AD hippocampal tissues. To confirm specificity of anti-Factor XIIIa antibody immunolabeling for E a s e , hippocampal tissues were incubated with the following parameters: (a) no primary antibody with secondary, and (b) primary antibody with a nonspecific secondary. These controls were negative in both AD and normal hippocampal tissues (data not shown).
Sections of AD hippocampus were immunolabeled with PHFl and anti-Factor XIIIa to determine the extent of co-labeling of neu-rons for both PHFlneurofibrillary inclusions and the presence of TGase, respectively. The NFTs are immunoreactive with PHFl because of the incorporation of PHFtau into the tangles (Greenberg and Davies, 1990) . Double immunofluorescence demonstrated that many neurons were co-labeled with both antibodies (Figures 3E  and 3F ), suggesting an association between the presence of NFTs and E a s e . The rationale for their dual presence is the conversion of soluble tau proteins into insoluble matrices through the activity of E a s e (Appelt et al., 1995) .
Discussion
Alzheimer's disease is characterized morphologically by the deposition of insoluble protein complexes (e.g., senile plaques containing amyloid fibrils, neurofibrillary tangles containing PHFtau) within selectively vulnerable areas of the brain, such as the hippocampus. These protein complexes comprise a variety of normal proteins that have undergone post-translational modifications resulting in abnormal conformations and accumulation. One such modification may involve the covalent crosslinking of vulnerable proteins by TGases. Previous investigations have demonstrated that P-amyloid (Dudek and Johnson, 1994; Rasmussen et al., 1994; Ikura et al., 1993) and tau (Appelt et al., 1995; Miller and Johnson, 1995; Dudek and Johnson, 1993) can be crosslinked by tissue E a s e in vitro. Although these studies demonstrated that P-amyloid and tau could be substrates for E a s e in vitro, the glutamyl-lysine bond catalyzed by E a s e has not been found in protein deposits from the AD brain. The demonstration of the isopeptide bond notwithstanding, this investigation focused on the localization of intracellular TGase(s) within neurons from the hippocampus in an effort to determine if this localization coincides with the neuronal degeneration characteristic of AD.
Studies of neuronal development have identified E a s e s as important enzymes for the maturation and stabilization of neurons in maintaining and establishing cell shape and connectivity (Ellisman and Porter, 1980) . Several studies have also demonstrated that TGases are involved in the developmental pathway of neuronal cells (Perry and Haynes, 1993; Matesz et al., 1991) . Our results substantiate and add to these earlier developmental studies by demonstrating intense immunolabeling for E a s e throughout the perikaryon and processes of embryonic rat hippocampal neurons in culture. TGases also have been implicated in catalyzing the formation of insoluble protein deposits in neuronal and non-neuronal cellsltissues (Loewy et al., 1988; Lorand et al., 1981) . Identification of E a s e s from human brain was demonstrated previously by biochemical analysis of crude homogenates (Selkoe et al., 1982) ; however, the precise localization within neuronal tissue was not determined. We have now identified E a s e within neurons located in (A,B) lmmunoreacted for E a s e with anti-Factor Xllla. Neurons in CA1-CA4 are highlighted by augmented immunoreactivity (arrowheads) in the perikaryon and neurites compared to the immunolabeled neurons (arrowheads) in normal hippocampal tissue (0). To verify the specificity of anti-Factor Xllla for neuronal Ease, sections from AD hippocampal tissue were incubated with preabsorbed anti-Factor Xllla antibody (C). The neurons in the sections incubated with the preabsorbed antibody were not immunoreactive. However, blood vessels in sections reacted with anti-Factor Xllla (A) and the preabsorbed antibody (C) were immunolabeled. Double immunofluoresence labeling of AD hippocampal tissue using PHFl and anti-Factor Xllla antibodies demonstrate that PHFl immunolabels NFTslPHFs throughout the perikaryon and neurites of degenerating neurons in the AD hippocampus (E, arrows) . Similarly, anti-Factor Xllla, which immunolabels TGase(s) within the neurons, co-labels those neurons immunoreactive for PHFl (F. arrows). In contrast to PHFl immunoreactivity, anti-Factor Xllla immunoreactivity only appears to be concentrated within the perikaryon. APPELT, KOPEN, BOYNE, BALIN areas of neurodegeneration in the AD brain after biochemical isolation and morphological analysis.
We have identified TGase within rat hippocampal neurons in culture, as well as in normal aged and AD hippocampal tissues from human brain, using an antibody to a member of the family of Eases, anti-coagulation Factor XIIIa. This polyclonal antibody was made to an extracellular E a s e and demonstrates specificity for guinea pig liver tissue E a s e , as revealed by the immunoreactive bands on Western blots. The observed immunoreactivity to the intracellular TGase presumably is the result of high homology among different forms of E a s e (Greenberg et al., 1991) . Our Western blotting of rat hippocampal cell homogenates and human hippocampal homogenates revealed protein bands of similar molecular weight. These results support previous data that demonstrate the high homology between TGase(s) found in different mammalian tissues as well as among different species (Gentile et al., 1991; Greenberg et al., 1991; Ikura et al., 1988) . Whether or not a similar homology is apparent in other regions of the brain and/or glial components throughout the CNS remains to be determined.
A pattern observed within both normal and AD brain was the immunolabeling for E a s e around cerebral blood vessels. This immunoreactivity was not diminished on immunoblots or tissues on preabsorbing the anti-Factor XIIIa antibody against tissue E a s e .
These results suggest either that the antibody recognizes Factor XI11 complexed within the extracellular matrix of the vessels or that a related E a s e protein may be present in the extracellular matrix. Complexes formed by the association of Factor XI11 with extracellular matrix proteins are not unprecedented. In particular, Factor XI11 has been shown to bind to the extracellular matrix of fibroblasts (Barry and Mosher, 1990) and to incorporate itself into fibrinogen and fibronectin on the extracellular surface of isolated hepatocytes (Barsigian et al., 1991) .
Our immunocytochemical findings from normal aged brain compared to AD brain show that E a s e is normally present within hippocampal neurons but that the immunoreactivity of %e appears to be greatly increased in neurons from the AD brain. Double immunofluorescent labeling of degenerating hippocampal neurons with PHF1, which was raised against aggregated PHFs (Greenberg et al., 1992) , and anti-Factor XIIIa indicates that E a s e may very well be associated with the intraneuronal neurofibrillary tangleslPHFs. Recent experiments suggest that TGase may interact directly as well as remain associated with PHFs isolated from AD NFTs (Appelt et al., 1995) . Furthermore, previous data support the interactions ofTGase with other cytoskeletal proteins found within mouse dermal fibroblasts (Trejo-Skalli et al., 1995) . At this time we can only speculate that E a s e is causative for the formation of NFTslPHFs, although in vitro studies in our laboratory ( A p pelt et al., 1995) and in others (Miller and Johnson, 1995; Dudek and Johnson, 1993) demonstrate that E a s e can catalyze the formation of insoluble macromolecular complexes from the tau protein.
The localization of %e within the AD hippocampal region suggests that this enzyme may be important in our understanding of a mechanistic pathway that may result in the abnormal accumulation of insoluble cytoskeletal complexes within vulnerable neurons in this area of the brain.
Xase(s) in AD may be expressed in greater abundance and/or with increased activity as a potential outcome ofa sequence of events leading to a recapitulation of development, or possibly as an outcome of changes in extracellular/intracellular ionic fluxes, particularly those involving calcium. With changes in the neuronal environment and with calcium dysregulation, as observed in AD (Michaelis, 1989 ). E a s e may be activated or reactivated as the result of direct calcium binding. There is suitable evidence linking Ease, a calcium-dependent enzyme, to apoptosis, which ultimately leads to physiological cell death (Fesus et al., 1987) . However, TGase involvement in cell death is not limited to apoptosis but is also implicated in necrobiosis (Iwaki et al., 1994) , in which histogenetic cell death is prominent. Increased induction and activation of TGase may contribute to the pathology of AD in the crosslinking of intraneuronal cytoplasmic proteins. In contradistinction, E a s e may be normally expressed, but other enzymatic regulatory mechanisms may be impaired, such as inactivation of isopeptidases that could cleave the lysine-glutamine bond (Ariel Loewy, personal communication).
Our results demonstrate the presence of %e within degenerative hippocampal neurons from the AD brain and its presence in some normal neuronal populations. This family of enzymes must be examined further for their potential role in the formation of insoluble intraneuronal macromolecular complexes that appear in AD. Increased concentrations of TGase andlor increased %e activity in neurons that are in various stages of degeneration may prove valuable for assessing the degree of pathogenic alterations within vulnerable neurons. An increased understanding of the biological functions of Ease(s) within the human CNS may provide an insight into mechanisms underlying human neurodegenerative diseases such as AD.
